An NT sgRNA, a KRAS-targeted sgRNA, and the 16 potential SOS2-targeted sgRNAs were each cloned into pLentiCRISPRv2, as previously described (33). sgRNA sequences are given in table S1. Lentiviruses were produced as described above. Forty-eight hours after infection, cells were selected for 4 days in puromycin at 6 μg/ml and then shifted into puromycin at 3 μg/ml for an additional 6 days. Ten days after selection, cells were analyzed for KRAS and SOS2 expression and plated for signaling and transformation assays.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.